These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4312434)

  • 1. Study of the reciprocal relationship of the exoantigens of Clostridium perfringens type A in the culture medium and the bacterial cells during cultivation.
    Shemanova GF; Gorshkova VI; Borisova OK; Shakhanina KL
    Folia Microbiol (Praha); 1970; 15(1):23-33. PubMed ID: 4312434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and function of Cl. perfringens toxin].
    Ispolatovskaia MV
    Vestn Akad Med Nauk SSSR; 1973; 28(11):83-9. PubMed ID: 4132138
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of the soluble antigens of strains of Cl. perfringens isolated from the feces of healthy persons].
    Goeva OE; Borovik EB; Sidorenko GI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):43-6. PubMed ID: 4308712
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of toxic enzymes of Clostridium perfringens BP6K on technologically important media including a medium with Tween 80.
    Lettl A
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):243-8. PubMed ID: 217931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunochemical study of the enzymes of a toxic complex of Cl. perfringens].
    Ispolatovskaia MV; Klimacheva LV; Tokinova TN; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):89-93. PubMed ID: 4327165
    [No Abstract]   [Full Text] [Related]  

  • 6. Large-scale production of clostridial collagenase and lecithinase C: short communication.
    Lettl A
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):385-8. PubMed ID: 4355336
    [No Abstract]   [Full Text] [Related]  

  • 7. [The isolation and properties of Clostridium perfringens collagenase].
    Levdikova GA
    Biokhimiia; 1966; 31(4):821-30. PubMed ID: 4299366
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.
    Smyth CJ; Arbuthnott JP
    J Med Microbiol; 1974 Feb; 7(1):41-66. PubMed ID: 4369079
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A.
    Nord CE; Möllby R; Smyth C; Wadström T
    J Gen Microbiol; 1974 Sep; 84(1):117-27. PubMed ID: 4373522
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some data in favor of the enzymatic nature of Cl. perfringens and oedematiens toxins].
    Zhak SP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):65-9. PubMed ID: 4290470
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of a vaccine against enterotoxemia from Clostridium perfringens strains isolated in the field].
    Cherfaoui S; Kadra B
    Arch Inst Pasteur Alger; 1992; 58():205-24. PubMed ID: 1309137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The study of the formation of lecithinase by Clostridium perfringens type A].
    Shemanova GF; Shakhanina KL; Vlasova EV; Borisova OK; Bakirov RD
    Biokhimiia; 1968; 33(3):561-9. PubMed ID: 4300426
    [No Abstract]   [Full Text] [Related]  

  • 13. [alpha-toxin (phospholipase C) of Clostridium perfringens (author's transl)].
    Ohsaka A
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():121-44. PubMed ID: 194279
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation and properties of lecithinase from Clostridium perfringens].
    Shemanova GF; Vlasova EV; Tsvetkov VS; Logunov AI; Levin FB
    Biokhimiia; 1968; 33(1):130-6. PubMed ID: 4299200
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of the enzymes of the toxic Cl. perfringens complex, their formation and interaction].
    Ispolatovskaia MV; Mikhaĭlovskaia LIa; Klimacheva LV; Blagoveshchenskiĭ VA; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):61-5. PubMed ID: 4290256
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 17. Serology of the soluble antigens of Clostridium perfringens types A-F by agar-gel diffusion.
    ELLNER PD; BOHAN CD
    J Bacteriol; 1962 Feb; 83(2):284-96. PubMed ID: 13890020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The toxins of Clostridium perfringens type C].
    Nedialkov S; Peichev B
    Vet Med Nauki; 1974; 11(2):73-8. PubMed ID: 4370604
    [No Abstract]   [Full Text] [Related]  

  • 19. [The variability of individual properties of subcultures of Cl. perfringens type A grown from separate colonies of strain BP6K (28)].
    Shemanova GF; Petrov RV; Borisova OK
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):85-9. PubMed ID: 4308062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of molasses and whey in culture media for the development and production of a toxin from Clostridium perfringens type D].
    Silva HJ; Giulietti AM; Segovia RF; Ertola RJ
    Rev Argent Microbiol; 1982; 14(2):85-90. PubMed ID: 6101000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.